The Royal College of Physicians responds to the inquiry by the Health and Social Care Select Committee on the impact of a no-deal for Brexit.

The House of Commons Health Select Committee has undertaken an inquiry on what the UK's regulatory arrangements will be after Brexit in order to ensure the safe and effective supply of medicines, medical devices, medical products and substances of human origin.

The NHS must ensure that patient care remains at the heart of the Brexit negotiations to ensure that UK patients can continue to access the latest treatments.

The RCP’s response calls on the government to introduce a positive and welcoming migratory system for doctors to ensure a sustainable and safe NHS.

The RCP has outlined the existing workforce challenges faced by the NHS, its reliance on recruitment from overseas and our concerns for the UK to attract physicians to the NHS in the future.

The RCP in Wales has responded to the National Assembly for Wales External Affairs and Additional Legislation Committee inquiry into the implications for Wales of Britain exiting the European Union. 

The RCP responds to the Health Select Committee's inquiry on the priorities for health and social care in the negotiations on the UK's withdrawal from the EU.

The RCP welcomes the opportunity to submit written evidence to this inquiry by the House of Commons Science and Technology Committee.